{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:39:26Z","timestamp":1725583166263},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,5]]},"DOI":"10.7759\/cureus.68718","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T15:22:55Z","timestamp":1725549775000},"source":"Crossref","is-referenced-by-count":0,"title":["Malignant Mesothelioma: Overcoming Diagnostic Hurdles"],"prefix":"10.7759","author":[{"given":"Priya Dharshini","family":"R","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Grace Priyadarshini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayaganesh","family":"P","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2010.12.024","article-title":"Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy","volume":"40","author":"Sugarbaker DJ","year":"2011","unstructured":"Sugarbaker DJ, Wolf AS, Chirieac LR, et al.. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy. Eur J Cardiothorac Surg. 2011, 40:298-303. 10.1016\/j.ejcts.2010.12.024","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13591","article-title":"Pleural mesothelioma (PMe): the evolving molecular knowledge of a rare and aggressive cancer","volume":"18","author":"Rigon M","year":"2024","unstructured":"Rigon M, Mutti L, Campanella M. Pleural mesothelioma (PMe): the evolving molecular knowledge of a rare and aggressive cancer. Mol Oncol. 2024, 18:797-814. 10.1002\/1878-0261.13591","journal-title":"Mol Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.36416\/1806-3756\/e20230343","article-title":"Identifying malignant mesothelioma by a pathological survey using the S\u00e3o Paulo state hospital cancer registry, Brazil","volume":"50","author":"Bernardi FD","year":"2024","unstructured":"Bernardi FD, Algranti E, Dolhnikoff M, et al.. Identifying malignant mesothelioma by a pathological survey using the S\u00e3o Paulo state hospital cancer registry, Brazil. J Bras Pneumol. 2024, 50:e20230343. 10.36416\/1806-3756\/e20230343","journal-title":"J Bras Pneumol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-20-2761","article-title":"Epidemiology, diagnosis and treatment of the malignant pleural mesothelioma, a narrative review of literature","volume":"13","author":"Schumann SO","year":"2021","unstructured":"Schumann SO, Kocher G, Minervini F. Epidemiology, diagnosis and treatment of the malignant pleural mesothelioma, a narrative review of literature. J Thorac Dis. 2021, 13:2510-23. 10.21037\/jtd-20-2761","journal-title":"J Thorac Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.33696\/immunology.2.042","article-title":"Current advances in CAR T cell therapy for malignant mesothelioma","volume":"2","author":"Klampatsa A","year":"2020","unstructured":"Klampatsa A, Albelda SM. Current advances in CAR T cell therapy for malignant mesothelioma. J Cell Immunol. 2020, 2:192-200. 10.33696\/immunology.2.042","journal-title":"J Cell Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31819f2e0e","article-title":"Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure","volume":"4","author":"Roberts HC","year":"2009","unstructured":"Roberts HC, Patsios DA, Paul NS, et al.. Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure. J Thorac Oncol. 2009, 4:620-8. 10.1097\/JTO.0b013e31819f2e0e","journal-title":"J Thorac Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.20360","article-title":"Assessment of global trends in the diagnosis of mesothelioma from 1990 to 2017","volume":"4","author":"Zhai Z","year":"2021","unstructured":"Zhai Z, Ruan J, Zheng Y, et al.. Assessment of global trends in the diagnosis of mesothelioma from 1990 to 2017. JAMA Netw Open. 2021, 4:e2120360. 10.1001\/jamanetworkopen.2021.20360","journal-title":"JAMA Netw Open"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12940-024-01094-y","article-title":"Air pollution and survival in patients with malignant mesothelioma and asbestos-related lung cancer: a follow-up study of 1591 patients in South Korea","volume":"23","author":"Huh DA","year":"2024","unstructured":"Huh DA, Choi YH, Kim L, et al.. Air pollution and survival in patients with malignant mesothelioma and asbestos-related lung cancer: a follow-up study of 1591 patients in South Korea. Environ Health. 2024, 23:56. 10.1186\/s12940-024-01094-y","journal-title":"Environ Health"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-22-2873","article-title":"Serum diagnostic markers for malignant pleural mesothelioma: a narrative review","volume":"11","author":"Wang JJ","year":"2022","unstructured":"Wang JJ, Yan L. Serum diagnostic markers for malignant pleural mesothelioma: a narrative review. Transl Cancer Res. 2022, 11:4434-40. 10.21037\/tcr-22-2873","journal-title":"Transl Cancer Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-042420-092719","article-title":"Diffuse pleural mesothelioma: advances in molecular pathogenesis, diagnosis, and treatment","volume":"19","author":"Febres-Aldana CA","year":"2024","unstructured":"Febres-Aldana CA, Fanaroff R, Offin M, Zauderer MG, Sauter JL, Yang SR, Ladanyi M. Diffuse pleural mesothelioma: advances in molecular pathogenesis, diagnosis, and treatment. Annu Rev Pathol. 2024, 19:11-42. 10.1146\/annurev-pathol-042420-092719","journal-title":"Annu Rev Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/oem.45.3.182","article-title":"Malignant mesothelioma in a cohort of asbestos insulation workers: clinical presentation, diagnosis, and causes of death","volume":"45","author":"Ribak J","year":"1988","unstructured":"Ribak J, Lilis R, Suzuki Y, Penner L, Selikoff IJ. Malignant mesothelioma in a cohort of asbestos insulation workers: clinical presentation, diagnosis, and causes of death. Br J Ind Med. 1988, 45:182-7. 10.1136\/oem.45.3.182","journal-title":"Br J Ind Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0063-2016","article-title":"Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment","volume":"25","author":"Bibby AC","year":"2016","unstructured":"Bibby AC, Tsim S, Kanellakis N, et al.. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment. Eur Respir Rev. 2016, 25:472-86. 10.1183\/16000617.0063-2016","journal-title":"Eur Respir Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2022.13560","article-title":"Usefulness of malignant pleural effusion for early cytological diagnosis of mesothelioma in situ: a case report","volume":"24","author":"Yabuuchi Y","year":"2022","unstructured":"Yabuuchi Y, Hiroshima K, Oshima H, et al.. Usefulness of malignant pleural effusion for early cytological diagnosis of mesothelioma in situ: a case report. Oncol Lett. 2022, 24:440. 10.3892\/ol.2022.13560","journal-title":"Oncol Lett"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12020371","article-title":"Unusual histology in mesothelioma: a report of two cases with a brief review","volume":"12","author":"Bono F","year":"2022","unstructured":"Bono F, Ceola S, Beretta C, Jaconi M. Unusual histology in mesothelioma: a report of two cases with a brief review. Diagnostics (Basel). 2022, 12:371. 10.3390\/diagnostics12020371","journal-title":"Diagnostics (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/jscr\/rjac002","article-title":"Cerebral metastases of malignant mesothelioma","volume":"2022","author":"Bathini A","year":"2022","unstructured":"Bathini A, Kusyk DM, Stabingas K, Kujawski B, Ahn J, Williamson R. Cerebral metastases of malignant mesothelioma. J Surg Case Rep. 2022, 2022:rjac002. 10.1093\/jscr\/rjac002","journal-title":"J Surg Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2009.02412.x","article-title":"Malignant pleural mesothelioma initially diagnosed on cervical lymph node biopsy","volume":"59","author":"Ogata S","year":"2009","unstructured":"Ogata S, Hiroi S, Tominaga A, et al.. Malignant pleural mesothelioma initially diagnosed on cervical lymph node biopsy. Pathol Int. 2009, 59:592-4. 10.1111\/j.1440-1827.2009.02412.x","journal-title":"Pathol Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2017.10.09","article-title":"Clinical diagnosis of malignant pleural mesothelioma","volume":"10","author":"Bianco A","year":"2018","unstructured":"Bianco A, Valente T, De Rimini ML, Sica G, Fiorelli A. Clinical diagnosis of malignant pleural mesothelioma. J Thorac Dis. 2018, 10:S253-61. 10.21037\/jtd.2017.10.09","journal-title":"J Thorac Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2021-217959","article-title":"Diagnostic sensitivity of pleural fluid cytology in malignant pleural effusions: systematic review and meta-analysis","volume":"78","author":"Kassirian S","year":"2023","unstructured":"Kassirian S, Hinton SN, Cuninghame S, et al.. Diagnostic sensitivity of pleural fluid cytology in malignant pleural effusions: systematic review and meta-analysis. Thorax. 2023, 78:32-40. 10.1136\/thoraxjnl-2021-217959","journal-title":"Thorax"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0804","article-title":"Integrative molecular characterization of malignant pleural mesothelioma","volume":"8","author":"Hmeljak J","year":"2018","unstructured":"Hmeljak J, Sanchez-Vega F, Hoadley KA, et al.. Integrative molecular characterization of malignant pleural mesothelioma. Cancer Discov. 2018, 8:1548-65. 10.1158\/2159-8290.CD-18-0804","journal-title":"Cancer Discov"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/291206-malignant-mesothelioma-overcoming-diagnostic-hurdles","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T15:22:59Z","timestamp":1725549779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/291206-malignant-mesothelioma-overcoming-diagnostic-hurdles"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.68718","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,5]]}}}